Marshall Wace LLP Takes Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Marshall Wace LLP bought a new position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 6,364 shares of the company’s stock, valued at approximately $422,000. Marshall Wace LLP owned about 0.06% of iShares U.S. Pharmaceuticals ETF at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Janney Montgomery Scott LLC raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 3.0% in the first quarter. Janney Montgomery Scott LLC now owns 12,489 shares of the company’s stock worth $848,000 after buying an additional 358 shares during the last quarter. &PARTNERS purchased a new position in iShares U.S. Pharmaceuticals ETF in the 2nd quarter worth $267,000. Texas Yale Capital Corp. lifted its position in iShares U.S. Pharmaceuticals ETF by 179.2% during the 1st quarter. Texas Yale Capital Corp. now owns 13,430 shares of the company’s stock worth $912,000 after acquiring an additional 8,620 shares during the period. Comerica Bank grew its stake in iShares U.S. Pharmaceuticals ETF by 71.6% during the 1st quarter. Comerica Bank now owns 1,462 shares of the company’s stock valued at $99,000 after purchasing an additional 610 shares during the last quarter. Finally, Mercer Global Advisors Inc. ADV increased its holdings in shares of iShares U.S. Pharmaceuticals ETF by 7.4% in the second quarter. Mercer Global Advisors Inc. ADV now owns 3,837 shares of the company’s stock valued at $254,000 after purchasing an additional 266 shares during the period.

iShares U.S. Pharmaceuticals ETF Stock Down 0.5 %

Shares of NYSEARCA:IHE opened at $70.25 on Friday. iShares U.S. Pharmaceuticals ETF has a 52-week low of $55.36 and a 52-week high of $72.94. The stock has a market cap of $709.53 million, a price-to-earnings ratio of 6.49 and a beta of 0.58. The business has a 50-day moving average price of $70.65 and a 200-day moving average price of $67.75.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.